diethylstilbestrol has been researched along with trelstar in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Belanger, A; Borsanyi, JP; Dupont, A; Emond, J; Giguere, M; Labrie, F; Lacourciere, Y; Monfette, G | 1 |
| Dupont, A; Labrie, F; Lachance, R; St Arnaud, R | 1 |
| Banka, CL; Erickson, GF | 1 |
1 trial(s) available for diethylstilbestrol and trelstar
| Article | Year |
|---|---|
Advantages of the combination therapy in previously untreated and treated patients with advanced prostate cancer.
Topics: Androgen Antagonists; Antineoplastic Agents; Buserelin; Clinical Trials as Topic; Combined Modality Therapy; Diethylstilbestrol; Flutamide; Follow-Up Studies; Gonadotropin-Releasing Hormone; Humans; Leuprolide; Male; Neoplasm Staging; Orchiectomy; Prostatic Neoplasms; Triptorelin Pamoate | 1986 |
2 other study(ies) available for diethylstilbestrol and trelstar
| Article | Year |
|---|---|
Serum luteinizing hormone (LH) biological activity in castrated patients with cancer of the prostate receiving a pure antiandrogen and in estrogen-pretreated patients treated with an LH-releasing hormone agonist and antiandrogen.
Topics: Aged; Anilides; Biological Assay; Combined Modality Therapy; Diethylstilbestrol; Drug Therapy, Combination; Flutamide; Gonadotropin-Releasing Hormone; Humans; Luteinizing Hormone; Male; Middle Aged; Orchiectomy; Prostatic Neoplasms; Radioimmunoassay; Time Factors; Triptorelin Pamoate | 1986 |
Gonadotropin-releasing hormone induces classical meiotic maturation in subpopulations of atretic preantral follicles.
Topics: Animals; Diethylstilbestrol; Dose-Response Relationship, Drug; Female; Follicular Atresia; Gonadotropin-Releasing Hormone; Meiosis; Ovarian Follicle; Rats; Rats, Inbred Strains; Time Factors; Triptorelin Pamoate | 1985 |